P450 enzymes are ubiquitous in nature and carry out a wide range of important reactions including the activation of carbon centers for catabolism, steroid metabolism, and detoxification of xenobiotics (1). Due to the important physiological functions of P450 enzymes, the reaction intermediates of P450 chemistry have been a subject of investigation for many years. Several discreet steps occur in the hydroxylation chemistry of the cytochrome P450s including: substrate binding, first electron transfer to the P450 from a physiological redox partner, oxygen binding (to form oxy-P450), a second electron transfer event (to form a reduced oxy or peroxo state), proton transfer to the distal oxygen (forming hydroperoxo), and an oxygen scission event producing a putative high valent iron-oxo species that subsequently generates hydroxylated product (2). The high valent iron-oxo has long been thought to be analogous to the activated iron species characterized in other oxidative enzymes (horseradish peroxidase (HRP), 1 catalase, and chloroperoxidase (CPO)) and referred to as Compound I, a ferryl-oxo-() porphyrin cation radical (3-5). The intermediates in the complex P450 reaction cycle have been gradually divulged through the use of a wide range of spectroscopic techniques (6 -8) and the use of methods that allow access to the fast steps occurring after O 2 binding (2, 9). Recently the peroxo and hydroperoxo intermediates have been observed through the use of cryoenzymology techniques combined with radiolysis, generating these intermediates through gradual temperature annealing (2, 10). Although there has been no identification of a Compound I intermediate by these techniques, it has been inferred by indirect measurements (2, 11, 12) . The Compound I state as well as the peroxo and hydroperoxo states of the enzyme have been proposed to be active in oxygenation events (13, 14) .
P450 enzymes are ubiquitous in nature and carry out a wide range of important reactions including the activation of carbon centers for catabolism, steroid metabolism, and detoxification of xenobiotics (1) . Due to the important physiological functions of P450 enzymes, the reaction intermediates of P450 chemistry have been a subject of investigation for many years. Several discreet steps occur in the hydroxylation chemistry of the cytochrome P450s including: substrate binding, first electron transfer to the P450 from a physiological redox partner, oxygen binding (to form oxy-P450), a second electron transfer event (to form a reduced oxy or peroxo state), proton transfer to the distal oxygen (forming hydroperoxo), and an oxygen scission event producing a putative high valent iron-oxo species that subsequently generates hydroxylated product (2) . The high valent iron-oxo has long been thought to be analogous to the activated iron species characterized in other oxidative enzymes (horseradish peroxidase (HRP), 1 catalase, and chloroperoxidase (CPO)) and referred to as Compound I, a ferryl-oxo-() porphyrin cation radical (3) (4) (5) . The intermediates in the complex P450 reaction cycle have been gradually divulged through the use of a wide range of spectroscopic techniques (6 -8) and the use of methods that allow access to the fast steps occurring after O 2 binding (2, 9) . Recently the peroxo and hydroperoxo intermediates have been observed through the use of cryoenzymology techniques combined with radiolysis, generating these intermediates through gradual temperature annealing (2, 10) . Although there has been no identification of a Compound I intermediate by these techniques, it has been inferred by indirect measurements (2, 11, 12) . The Compound I state as well as the peroxo and hydroperoxo states of the enzyme have been proposed to be active in oxygenation events (13, 14) .
To probe the nature of Compound I, meta-chloroperoxybenzoic acid (m-CPBA) has been used as an oxidizing agent to produce this high valent iron-oxo through heterolytic cleavage of the organic peroxide in CPO and HRP. The Compound I species of CPO and HRP have sufficient half-lives for resonance Raman and EPR studies and have been well characterized (3, 5, (15) (16) (17) . The same peroxy acid and its derivatives have been used with P450s in attempts to generate intermediates. Evidence for the existence of Compound I in P450s was demonstrated through substrate oxygenation or hydroxylation in the reaction of various organic peroxides with either liver microsomal P450 or CYP101, respectively (18, 19, 21) .
Contrary to the evidence for Compound I formation in cytochrome P450 using m-CPBA, Blake and Coon (20) reported that the reactions of several peroxy acids with CYP2B4 generated other active species, which are neither Compound I nor its one-electron-reduced adduct (Compound II). However, in previous studies the generation of the Compound I intermediate in cytochrome P450 (CYP101) required a large excess of peroxyacid, leading to the rapid formation, then conversion of Compound I to other species. This inherent reactivity of CYP101 from Pseudomonas putida has made the identification of Compound I tenuous, and, despite numerous efforts, kinetic analysis could not be completed in the 10-ms time regime of the intermediate's existence (21, 22) .
To provide a characterization of the spectral properties of Compound I in a thiolate-liganded heme protein, Harris et al. calculated the spectrum of methylmercaptooxyferryl protoporphyrin IX using density functional theory (DFT) (23) . The calculated spectrum had a split Soret blue shifted from the ferric Soret maximum by 60 nm with the Q bands appearing at 690 nm. Recently, Mössbauer and EPR spectroscopic studies of freeze-quenched samples from the reaction of m-CPBA with CYP101 demonstrated the existence of an organic radical and a ferryl species (24) . The techniques employed were not fast enough to capture the Compound I intermediate on the path to the observed ferryl-radical species. Again, the high concentration of m-CPBA used in these studies leads to degradation of protein, which further complicates data analysis.
CYP119 is a thermostable P450 isolated from Sulfolobus solfataricus with a melting temperature of 91°C and remarkable stability to pressure denaturation (25, 26) . Thermostable enzymes are thought to have more rigid active site structures at room temperature than their mesophilic counterparts, which could lead to a slowing of individual steps in the catalytic cycle (27) . This alteration in relative reaction rates may enable the resolution of intermediates that occur too rapidly to be characterized in their mesophilic counterparts.
CYP119 has proven to be an effective model system for the study of the intermediate states of the reaction cycle of this P450. For instance, we recently employed cryoenzymology to define the hydroperoxo state resulting from the one-electron reduction of the ferrous dioxygen state (28) . In this communication, we report the reaction kinetics of ferric CYP119 with m-CPBA using stopped-flow spectroscopy and document the formation of a spectral intermediate with the characteristic spectrum of Compound I. The relevant time scales of formation and breakdown of Compound I in this thermophilic P450 are such that a kinetic characterization of these processes under various conditions can be obtained for the first time.
EXPERIMENTAL PROCEDURES m-CPBA was purchased from Aldrich-Sigma and purified using the method described by Davies et al. (29) . Briefly, m-CPBA was re-crystallized in a 1:3 ether/petroleum ether solution and characterized by NMR. Solutions of m-CPBA for kinetic studies were prepared by addition of an acetone stock. The m-CPBA concentrations were determined by iodide oxidation to triiodide with the extinction coefficient of 25.5 mM Ϫ1 cm Ϫ1 at 353 nm (30) . Cytochrome P450 CYP119 expression and purification from Escherichia coli are as published previously (26, 31) . Protein concentration was determined based on the Soret maximum at 415 nm (⑀ ϭ 104 mM Ϫ1 cm Ϫ1 ). All steady-state UV-visible spectra were recorded on a Hitachi U3300 spectrophotometer. Single wavelength stopped-flow measurements were performed on a KinTek (Austin, TX) model SF-2001 stopped-flow system at 4°C. For multiple-wavelength absorption studies, a stopped-flow apparatus (model SX-18MV) and the associated computer system from Applied Photophysics (Surrey, UK) were used. Multiple-wavelength absorption studies were carried out using a photodiode array detector and X-SCAN software (Applied Photophysics, Ltd.). The dead-time of this instrument is about two milliseconds. In a typical experiment one syringe contained CYP119 (6 M heme) buffered in 100 mM phosphate (at various pH), and the other contained various concentrations of m-CPBA. The reaction temperature was controlled by a water bath. Spectral deconvolution and kinetic analysis were performed by global analysis and numerical integration methods using PRO-K software (Applied Photophysics, Ltd.).
RESULTS
Reaction kinetics of m-CPBA with ferric CYP119 were first obtained by following the decay of the ferric signal at 415 nm and a concurrent increase of absorption at 370 nm. Various m-CPBA/CYP119 concentration ratios were investigated, as shown in Fig. 1 . At m-CPBA concentrations less than half that of the ferric protein, the absorption kinetics clearly show the formation of an intermediate by a second order process. The spectral intermediate then decays in a first order manner, with the spectrum returning to that of a ferric enzyme. At 21 M CYP119 and an m-CPBA concentration of 1.25, 2.5, and 5 M, the maximal observed absorbance change corresponds to 1, 2.1, and 3.4% of the total enzyme concentration, respectively. At higher m-CPBA concentrations, more complicated kinetic behavior was observed, with a broadband decrease in absorbance indicating protein decomposition (see "Discussion"). Note that at high m-CPBA concentrations there appears to be a departure from first order decomposition process, indicating a combination of protein destruction and side oxidation processes. To better characterize the first intermediate formed in this reaction, multi-wavelength kinetic measurements were carried out at low m-CPBA concentrations.
Rapid-scan stopped-flow spectrophotometry, together with singular value decomposition, was used to provide spectral identification of the observed intermediate. In this case, full spectra as a function of time were analyzed using the following model. 
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The spectra of the ferric protein and Intermediate I as well as the kinetic trace of each species involved were resolved (Fig. 3) . To probe the role of proton concentration on Compound I formation, the reaction between CYP119 and m-CPBA was studied as a function of pH by means of multi-wavelength measurements. The rates of formation and decay for compound I in CYP119 at different pH are shown in Table I . Additionally, the rates of formation and decay for Compound I were increased with an increase in reaction temperature. The Arrhenius plot (data not shown) for the Compound I formation reaction (k 1 ) equates to an E a ϭ 14.1 kcal/mole and the decay rate (k 2 ) E a ϭ 18.1 kcal/mol.
DISCUSSION
The thermostable cytochrome P450 CYP119 has proven to be an excellent system for investigating the nature of intermediates with higher oxidation states of this important class of heme proteins. Previous attempts to form and isolate a Compound I intermediate in CYP101 and other P450s were hampered by the use of a large excess of peroxyacids, leading to rapid progression from Compound I to other intermediates and concomitant protein destruction (21, 24) . The formation of Compound I in CYP119 was slowed both by the use of lower concentrations of m-CPBA and by the temperature at which the experiments were carried out (4°C), which was well below the physiological temperature for this thermophilic enzyme (80°C). This allowed the detection of an intermediate clearly defined as Compound I well within the time scale accessible by stopped-flow spectroscopy. Protein degradation, which can often complicate kinetic analysis, was largely avoided. These properties of Compound I formation in CYP119 have made the spectral and kinetic characterization of this previously elusive chemical species in P450s possible.
CYP119 is capable of forming an intermediate with the spectral characteristics of a Compound I, ferryl-oxo-() porphyrin cation radical, when rapidly mixed with the peroxy acid m-CPBA. The spectral similarities of the CYP119 Compound I to the optical spectra of Compound I in other heme proteins are summarized in Table II . The Soret band of this Compound I was asymmetric and single-peaked at 370 nm (Fig. 3A) , while asymmetric Soret bands of both CYP101 and CPO are at 367 nm (21, 32) . This asymmetric feature has been deconvoluted using Gaussian-type transition bands and assigned as the splitting Soret band of the d-type hyper-porphyrin in the recent spectroscopic studies of CPO Compound I (16) . Moreover, the visible spectrum of CYP119 Compound I has almost identical absorption intensity at 610 and 690 nm, whereas the intensity at 610 nm of CPO Compound I is lower than its absorption at 688 nm. Overall, these findings indicate the similarity between the Compound I entity of these two thiolate-ligated heme proteins and the minor differences in the absorption spectra can be attributed to their electronic structure differences. Similar spectral characteristics of P450 Compound I have also been generated from DFT calculations by Harris et al. (23) . The calculated spectra of the methylmercaptooxyferryl protoporphyrin IX model structure are blue-shifted by 50 -60 nm in both the ferric resting state and Compound I; however, the other features and the peak shapes are quite similar to the results presented here. The major peak in the split Soret band of the calculated Compound I spectrum is blue-shifted from the ferric Soret by 60 nm, similar to the 45 nm shift in the CYP119 Compound I. Additionally, the Q-bands of the calculated Compound I are shifted to 690 nm, with the equivalent bands in the same location for CYP119 Compound I.
The reaction of CYP101 with m-CPBA was shown by Egawa et al. (21) to form an intermediate with spectral characteristics similar to those of CYP119 Compound I. However, this intermediate was formed in the dead-time of the stopped-flow instrument used and decomposed rapidly into a series of unidentified intermediates. The high concentration of peracid used also caused breakdown of the protein. The experimental conditions necessary to generate the putative Compound I in CYP101 included the use of a 30-fold excess of m-CPBA, increasing the formation rate to the point that the intermediate was fleetingly formed and rapidly decayed. The Compound I, formed under the conditions presented here, in CYP119 has a half-life more than an order of magnitude longer than the apparent CYP101 half-life with high concentrations of m-CPBA. This longer half-life has allowed the first kinetic characterization of the formation and decomposition processes for Compound I in a P450. To compare the reaction kinetics of CYP119 Compound I with other heme proteins, rate constants 
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for Compound I formation and decay in various systems are summarized in Table III . While the Compound I states of the other three proteins are stable enough to detect at room temperature, characterization of a P450 Compound I species necessitated the utilization of a thermophilic protein and low temperature (4°C). The kinetic competence in the conversion of the observed intermediate to an oxygenated product would be a valuable piece of information. Unfortunately, the physiological substrate for this enzyme is not known. However, the addition of laurate to the reaction mixture in a double mixing configuration after the addition of m-CPBA leads to complete quenching of the observed spectral intermediate within the dead-time of the instrument. The reaction of a Compound I intermediate with juxtaposed substrate has been suggested to be very fast, and hence we do not expect to directly observe the kinetic conversion to product. Analysis of the reaction mixture following addition of laurate in this double-mix experiment demonstrated the presence of hydroxylaurate as a product (data not shown), suggesting the coupling of intermediate decay to substrate oxygenation.
The pH dependence for Compound I formation reflects the pK of m-CPBA of 7.4. Previous data have shown that the protonated form of m-CPBA is the active species for Compound I formation, leading to increased rates of Compound I formation at lower pH (20) . The pH dependence of the m-CPBA reaction with CYP119 is similar to the behavior of catalase reacting with peroxyacetic acid (33) . In both cases the results are most simply interpreted as a reaction between the enzyme and non-ionized peroxy acid molecules. This is substantiated by similar pH dependence for the reaction between peroxybenzoic acid and horseradish peroxidase (29) . Additionally, the E a for Compound I formation (14.1 kcal/mol) in CYP119 is relatively high compared with the reaction of hydrogen peroxide with peroxidases (2.5-5 kcal/mol) that utilize hydrogen peroxide as a substrate (34) . This is in agreement with the recent findings for the reaction of prostaglandin endoperoxide synthase with hydrogen peroxide, which also has an elevated E a (ϳ24 kcal/ mol) of its Compound I formation and does not use hydrogen peroxide as a native substrate (35) .
The disappearance of CYP119 Compound I is a first order process. This makes it unlikely that the degradation of Compound I involves O 2 formation by nucleophilic attack of a second m-CPBA molecule as observed in chloroperoxidase (32) . Similarly, the possibility of the formation of Compound II from the reaction of Compound I with a second peroxy acid molecule as in HRP can be ruled out. One possibility is that the oxene oxygen is transferred to the protein. Alternatively, it has been suggested that the slow regeneration of the ferric state in catalase, from Compound I, is carried out by a reducing equivalent originating from the protein matrix (33, 36) . The CYP119 Compound I decays to the low-spin ferric form at a rate about 10 5 times faster than that of catalase Compound I. These active species can be reduced by any adventitious reducing equivalent from the protein matrix (4). The pH dependence of the Compound I decomposition rate is similar to the decay of ferryl intermediate in cytochrome c oxidase, which was explained by an auto-reduction pathway (37) . Taken together, the mechanism of degradation of CYP119 Compound I and the regeneration of the ferric enzyme can only be determined with more experimental analysis.
The kinetic characterization of Compound I formation in CYP119 has allowed for the optimization of conditions for the maximal production of this putative reaction intermediate in time regimes accessible to other spectroscopic methods. The information thus obtained will aid in the further determination of the nature of Compound I in P450 reactions.
